NVKN

Hybrid symposium: 

 

“Insights and new developments in treatment of PHVD in preterm infants”

 

11 May 2022 University Medical Center Utrecht 

 

Even though mortality has been decreasing over the last few decades, our preterm infants are still at risk of developing an intraventricular haemorrhage and when the haemorrhage is severe posthaemorrhagic ventricular dilatation (PHVD) is a common complication. 

As clinical symptoms occur very late, PHVD used to be treated late, when the ventricles were already severely dilated and the head circumference had started to increase rapidly. Following two important randomized controlled trials (DRIFT led by Andy Whitelaw in Bristol and ELVIS led by the UMC Utrecht team) treatment policies are changing, as both studies showed improved neurodevelopmental outcome with intervention prior to the onset of clinical symptoms. 

On May 12 2022 Mehmet Cizmeci, MD will defend his PhD thesis: “Neonatal Haemorrhagic Brain Injury: Optimizing Treatment and Outcome”, in which he reports in detail the results of the ELVIS trial, but also the complications seen following CSF removal from necessary neurosurgical interventions. The symposium will also cover new noninvasive methods to assess PHVD and new neurosurgical and neuroprotective strategies, presented by experts from abroad.   

We would like to invite you to our hybrid symposium, organized by the departments of Neurosurgery and Neonatology of the UMC Utrecht

 

On behalf of the organizing committee

Dr. Floris Groenendaal

Dr Peter Woerdeman

Em. Prof. Linda de Vries

 

This symposium will take place on Wednesday May 11 2022, 13:00-17:30 h

Location: University Medical Center Utrecht, Auditorium Van Peperzeelzaal 

Heidelberglaan 100

3484 CX Utrecht

Or online following registration

 

This will be a hybrid meeting and we hope to welcome many of you in Utrecht. The maximum size of the audience in the UMC Utrecht will be dependent on Covid-19 regulations.

 

Costs: free of charge after registration (K.Warkor@umcutrecht.nl) 

 

Programme:

13.00-13.30
Optimizing treatment of PHVD

Mehmet Cizmeci

Consultant Neonatologist; Hospital for Sick Children, Toronto, Canada

 

 

13.30-14.00
The use of intraventricular stemcells for severe intraventricular haemorrhage 

So Yoon Ahn

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

 

14.00-14.30
DRIFT, the past and the future

Andrew Whitelaw

Em. Professor Neonatology; Southmead Hospital, School of clinical science; University of Bristol, UK

 

14.30-15.00
The role of Neuroendoscopic Lavage 

Ulrich-Wilhelm Thomale

Pediatric Neurosurgeon, Campus Virchow Klinikum, Charité

Universitätsmedizin Berlin, Germany

 

15.00-15.15 tea break

 

15.30-16.00
Treatment based on clinical symptoms or cUS measurements 

Lara Leijser

Associate Professor; Consultant Neonatologist; Department of Pediatrics, University of Calgary, Calgary, AB, Canada

 

16.00-16.30

The use of DTI in PHVD 

Niek van der Aa

Fellow Neonatology, Department Neonatology, University Medical Center Utrecht, Netherlands

 

16.30-17.00

The role of NIRS in PHVD

Thomas Alderliesten

Department of Neonatology, Department Neonatology, University Medical Center Utrecht, Netherlands

 

17.00-17.30

CSF biomarkers and it’s relation to shunt dependence

Dave Limbrick

Neurosurgeon; Department of Pediatrics, Washington University; School of Medicine, St. Louis, Missouri, USA

 

Accreditatie: Voor deze nascholing zijn accreditatiepunten

aangevraagd bij het NVK, NVKN, Neurochirurgie